Global X Long Term US Treasury Premium Yield ETF News - LPAY.U

Packer backs Crown Resorts Ltd with $200 million bet

http://www.fool.com.au/2015/11/11/packer-backs-crown-resorts-ltd-with-200-million-bet/?utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub

UPDATE: FDA 'Unclear' If Avastin Data Backs Expanded Approval

The Food and Drug Administration said it's "unclear" whether positive responses seen in clinical trials involving Genentech Inc.'s (DNA) Avastin...

FDA 'Unclear' If Genentech Drug Data Backs Expanded Approval

The Food and Drug Administration said it's "unclear" whether positive responses seen in clinical trials involving Genentech Inc.'s (DNA) Avastin...

UPDATE: Roche Effectively Seals $46.8 Billion Genentech Takeover

Swiss drugmaker Roche Holding AG (ROG.VX) said Thursday it holds 93.2% of Genentech Inc. (DNA) shares following the completion of its tender...

Roche Completes Genentech Takeover, Holds 93.2%

Swiss drugmaker Roche Holding AG (ROG.VX) said Thursday it holds 93.2% of Genentech Inc. (DNA) shares following the completion of its tender...

Roche Completes Tender Offer For Genentech, Holds 93.2%

Swiss drugmaker Roche Holding AG (ROG.VX) said Thursday it holds 93.2% of Genentech Inc (DNA) shares after completion of the tender offer, with 3...

2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan

Shareholder activist Ethos Wednesday called for UBS AG (UBS) shareholders to reject an overhaul of the Swiss bank's pay practices at an April 15...

UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGM

Shareholder activist Ethos Wednesday called for UBS AG (UBS) shareholders to reject an overhaul to the Swiss bank's pay practices at an April 15...

Roche Says RiskMetrics Backs Genentech Takeover At $95/Share

Roche Holding AG (RHHBY) said Tuesday RiskMetrics recommends Genentech Inc. (DNA) shareholders accept the Swiss drug company's $95-a-share...

EU Panel Backs Novartis' Glivec In Kit-positive GIST

The European Union advisory panel to the drug regulator gave a positive opinion to extend teh indication for Novartis AG's (NVS) Glivec to include...

Roche Shares Down On Actemra; Herceptin Success Of Little Help

Roche Holding AG's (ROG.VX) shares fell Wednesday as investors' risk adversity apparently won the upper hand when the company reported positive...

Roche's Herceptin Extends Life In Aggressive Stomach Cancer

Drugmaker Roche Holding AG (ROG.VX) said Wednesday that new data shows its breast cancer drug Herceptin also shows benefits when used to treat...

Roche: Herceptin Prolongs Life In Stomach Cancer

Roche Holding AG (ROG.VX) said Wednesday that results from a major international study show that adding Herceptin (trastuzumab) to standard...

UPDATE: Chugai,Roche Face Arthritis Drug Side Effect Setback

In a major setback for drug giant Roche Holding AG (ROG.VX), its Japanese unit Chugai Pharmaceutical Co. (4519.TO) Wednesday said a study here...

Chugai:Undeniable Actemra Side Effects Tied To Patient Deaths

Chugai Pharmaceutical Co. (4519.TO) said Wednesday that it is undeniable that its rheumatoid arthritis drug Actemra might be a causal factor in...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Global X Long Term US Treasury Premium Yield ETF (LPAY.U)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LPAY.U News

Packer backs Crown Resorts Ltd with $200 million bet

UPDATE: FDA 'Unclear' If Avastin Data Backs Expanded Approval

FDA 'Unclear' If Genentech Drug Data Backs Expanded Approval

UPDATE: Roche Effectively Seals $46.8 Billion Genentech Takeover

Roche Completes Genentech Takeover, Holds 93.2%

Roche Completes Tender Offer For Genentech, Holds 93.2%

2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan

UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGM

Roche Says RiskMetrics Backs Genentech Takeover At $95/Share

EU Panel Backs Novartis' Glivec In Kit-positive GIST

Roche Shares Down On Actemra; Herceptin Success Of Little Help

Roche's Herceptin Extends Life In Aggressive Stomach Cancer

Roche: Herceptin Prolongs Life In Stomach Cancer

UPDATE: Chugai,Roche Face Arthritis Drug Side Effect Setback

Chugai:Undeniable Actemra Side Effects Tied To Patient Deaths

LPAY.U Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Global X Long Term US Treasury Premium Yield ETF (LPAY.U) News

Global X Long Term US Treasury Premium Yield ETF (LPAY.U)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LPAY.U News

Packer backs Crown Resorts Ltd with $200 million bet

UPDATE: FDA 'Unclear' If Avastin Data Backs Expanded Approval

FDA 'Unclear' If Genentech Drug Data Backs Expanded Approval

UPDATE: Roche Effectively Seals $46.8 Billion Genentech Takeover

Roche Completes Genentech Takeover, Holds 93.2%

Roche Completes Tender Offer For Genentech, Holds 93.2%

2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan

UPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGM

Roche Says RiskMetrics Backs Genentech Takeover At $95/Share

EU Panel Backs Novartis' Glivec In Kit-positive GIST

Roche Shares Down On Actemra; Herceptin Success Of Little Help

Roche's Herceptin Extends Life In Aggressive Stomach Cancer

Roche: Herceptin Prolongs Life In Stomach Cancer

UPDATE: Chugai,Roche Face Arthritis Drug Side Effect Setback

Chugai:Undeniable Actemra Side Effects Tied To Patient Deaths

LPAY.U Discussion

Your Recent History